hat
Methandrostenolòn te orijinèlman devlope nan 1955 pa CIBA ak commercialisés nan peyi Almay ak Etazini yo.Kan pwodwi CIBA Dianabol, Methandrostenolone byen vit te vin premye a AAS lajman itilize nan mitan atlèt pwofesyonèl ak amatè, epi li rete AAS ki pi komen oral aktif pou itilizasyon ki pa medikal . Kòmanse pli vit apre sa nan 1959, CIBA te kolabore ak John Bosley Ziegler (yon doktè ki espesyalize nan reyabilitasyon fizik ak yon pyonye bonè nan amelyorasyon pèfòmans pharmaceutique) pou teste efè Dianabol sou weightlifters pwofesyonèl. Ziegler te gen yon relasyon pwòch ak Bob Hoffman, pwopriyetè Konpayi Barbell York ak antrenè ekip Olympic pwa poul Olympic, akòde li aksè a matyè nan kondisyon pèfòmans pik.
eng
Methandrostenolone was originally developed in 1955 by CIBA and marketed in Germany and the United States.As the CIBA product Dianabol, Methandrostenolone quickly became the first widely used AAS among professional and amateur athletes, and remains the most common orally active AAS for non-medical use. Beginning soon afterwards in 1959, CIBA collaborated with John Bosley Ziegler (a physician specializing in physical rehabilitation and an early pioneer of pharmaceutical performance enhancement) to test the effects of Dianabol on professional weightlifters. Ziegler had a close relationship with Bob Hoffman, owner of York Barbell Company and coach of the U.S. Olympic weightlifting team, granting him access to subjects in peak performance condition.